About the Authors
- Frank W Rockhold
-
*To whom correspondence should be addressed. E-mail: ronald.l.krall@gsk.com (RLK), E-mail: frank.w.rockhold@gsk.com (FWR)
Affiliation GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America
- Ronald L Krall
-
*To whom correspondence should be addressed. E-mail: ronald.l.krall@gsk.com (RLK), E-mail: frank.w.rockhold@gsk.com (FWR)
Affiliation GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America
Competing Interests
The authors have declared that no competing interests exist.